Loading...
*  Norepinephrine transporter
This requires norepinephrine to diffuse from the site it is released to the transporter for reuptake. Norepinephrine ... norepinephrine) transporter and consequently a phenotype of impaired neuronal reuptake of norepinephrine has been implicated in ... norepinephrine-dopamine reuptake inhibitors (NDRIs), norepinephrine reuptake inhibitors (NRIs or NERIs) and the tricyclic ... "Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and ...
*  Talopram
... (Lu 3-010), also known as phthalapromine, is a selective norepinephrine reuptake inhibitor (NRI) which was researched ... "From the Selective Serotonin Transporter Inhibitor Citalopram to the Selective Norepinephrine Transporter Inhibitor Talopram: ...
*  Norepinephrine
The general function of norepinephrine is to mobilize the brain and body for action. Norepinephrine release is lowest during ... A significant part of the damage is due to the effects of sustained norepinephrine release, because of norepinephrine's general ... A variety of medically important drugs work by altering the actions of norepinephrine systems. Norepinephrine itself is widely ... Once in the synapse, norepinephrine binds to and activates receptors. After an action potential, the norepinephrine molecules ...
*  Alpha blocker
Specifically, norepinephrine and epinephrine are secreted by these tumors, either continuously or intermittently. The excess ... This drug blocks the activity of epinephrine and norepinephrine by antagonizing the alpha receptors, thus decreasing vascular ... been efficacious in treating patients with PTSD induced nightmares due to its ability to block the effects of norepinephrine. ...
*  Phentolamine
... typically of norepinephrine. Epinephrine infusions are less vasoconstrictive than norepinephrine as they primarily stimulate β ... By abolishing this negative feedback phentolamine leads to even less regulated norepinephrine release, which results in a more ... releasing norepinephrine. In response, the β1 adrenergic receptors on the heart increase its rate, contractility, and ... which function predominantly as presynaptic negative feedback for norepinephrine release. ...
*  Norepinephrine (medication)
Norepinephrine acts on beta-1 adrenergic receptors, causing increase in heart rate and cardiac output. Norepinephrine is the ... Norepinephrine works by binding and activating alpha adrenergic receptors. Norepinephrine was discovered in 1946 and was ... Norepinephrine, also known as noradrenaline, is a medication used to treat people with very low blood pressure. It is the ... Norepinephrine is used mainly as a sympathomimetic drug to treat people in vasodilatory shock states such as septic shock and ...
*  Norepinephrine releasing agent
A norepinephrine releasing agent (NRA), also known as an adrenergic releasing agent, is a catecholaminergic type of drug which ... A closely related type of drug is a norepinephrine reuptake inhibitor (NRI). Another class of drugs that stimulates adrenergic ... This in turn leads to increased extracellular concentrations of norepinephrine and epinephrine therefore an increase in ... induces the release of norepinephrine (noradrenaline) and epinephrine (adrenaline) from the pre-synaptic neuron into the ...
*  Norepinephrine reuptake inhibitor
A norepinephrine reuptake inhibitor (NRI, NERI) or adrenergic reuptake inhibitor (ARI), is a type of drug that acts as a ... However, norepinephrine has been implicated as acting synergistically with dopamine when actions on the two neurotransmitters ... A closely related type of drug is a norepinephrine releasing agent (NRA). Many NRIs exist, including the following: Pure ... A meta analysis published in BMJ in 2011 concluded that the selective norepinephrine reuptake inhibitor reboxetine is ...
*  Norepinephrine-dopamine disinhibitor
Norepinephrine and dopamine disinhibitors (NDDIs) are a class of drugs which act at specific sites to disinhibit downstream ... Flibanserin disinhibits norepinephrine and dopamine release in the prefrontal cortex by activating 5-HT1A receptors in this ... Agomelatine, an antidepressant which disinhibits norepinephrine and dopamine release in the frontal cortex by antagonizing 5- ... Stahl SM (October 2007). "Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus ...
*  Norepinephrine-dopamine releasing agent
A norepinephrine-dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine ... A closely related type of drug is a norepinephrine-dopamine reuptake inhibitor (NDRI). Monoamine releasing agent. ...
*  Norepinephrine-dopamine reuptake inhibitor
A closely related type of drug is a norepinephrine-dopamine releasing agent (NDRA). Norepinephrine-dopamine reuptake inhibitors ... A norepinephrine-dopamine reuptake inhibitor (NDRI) is a drug that acts as a reuptake inhibitor for the neurotransmitters ... This in turn leads to increased extracellular concentrations of both norepinephrine and dopamine and, therefore, an increase in ... Stahl, S. M. (2004). "A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor". ...
*  Serotonin-norepinephrine reuptake inhibitor
2005). "Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine ... normal levels of norepinephrine in the synaptic clefts. Overall, inhibition of norepinephrine reuptake induced by TCAs, leads ... while milnacipran is three times more selective for norepinephrine than serotonin. Elevation of norepinephrine levels is ... Atomoxetine-a norepinephrine-predominant SNRI used in the treatment of ADHD and, off-label, major depression. Was approved by ...
*  Serotonin-norepinephrine releasing agent
A serotonin-norepinephrine releasing agent (SNRA) is a type of drug which induces the release of serotonin and norepinephrine ( ... A closely related type of drug is a serotonin-norepinephrine reuptake inhibitor (SNRI). Monoamine releasing agent Serotonin ... releasing agent Norepinephrine releasing agent Serotonin-dopamine releasing agent Serotonin-norepinephrine-dopamine releasing ... a norepinephrine releasing agent, is a functional SNRA that was formerly used as an appetite suppressant for the treatment of ...
*  Serotonin-norepinephrine-dopamine releasing agent
Monoamine releasing agent Norepinephrine-dopamine releasing agent Serotonin-dopamine releasing agent Serotonin-norepinephrine ... A serotonin-norepinephrine-dopamine releasing agent (SNDRA), also known as a triple releasing agent (TRA), is a type of drug ... A closely related type of drug is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). Examples of SNDRAs include ... which induces the release of serotonin, norepinephrine/epinephrine, and dopamine in the brain and body. SNDRAs produce ...
*  Serotonin-norepinephrine-dopamine reuptake inhibitor
... norepinephrine, and dopamine. It does this by concomitantly inhibiting the serotonin transporter (SERT), norepinephrine ... A serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), also known as a triple reuptake inhibitor (TRI), is a type of ... The mood changes induced by AMPT may be mediated by decreases in norepinephrine, while changes in selective attention and ... They are also very similar to serotonin-norepinephrine-dopamine releasing agents (SNDRAs) like MDMA ("ecstasy") and α- ...
*  Atypical antipsychotic
... which is why weight gain occurs with some antipsychotics if the norepinephrine is not inhibited. Inhibition of norepinephrine ... Increased norepinephrine can cause increased glucose levels, which is to say blood sugar levels. Increased blood sugar levels ... "norepinephrine". Cardiosmart.org. 2010-12-15. Retrieved 2016-09-30. Veves A, Malik RA (2008-02-01). Diabetic Neuropathy: ... The atypical antipsychotics integrate with the serotonin (5-HT), norepinephrine (α, β), and dopamine (D) receptors in order to ...
*  Antidepressant
Serotonin-norepinephrine reuptake inhibitors (SNRIs) are potent inhibitors of the reuptake of serotonin and norepinephrine. ... serotonin-norepinephrine reuptake inhibitors (SNRIs) and norepinephrine reuptake inhibitors (NRIs). Adverse effects have been ... Norepinephrine reuptake inhibitors (NRIs or NERIs) are a type of drug that acts as a reuptake inhibitor for the ... However, norepinephrine has been implicated as acting synergistically with dopamine when actions on the two neurotransmitters ...
*  D-DOPA
Norepinephrine (Noradrenaline; Levophed, etc.) Epinephrine (Adrenaline; Adrenalin, EpiPen, Twinject, etc.). ...
*  Neuropeptide
Norepinephrine (noradrenaline). In neurons of the A2 cell group in the nucleus of the solitary tract), norepinephrine co-exists ...
*  Methyldopa
Dopamine is a precursor for norepinephrine (noradrenaline) and subsequently epinephrine (adrenaline). This inhibition results ... Norepinephrine (noradrenaline; Levophed, etc.) Epinephrine (adrenaline; Adrenalin, EpiPed, Twinject, etc.) "Methyldopa". The ...
*  Epinephrine
Oxidation gives norepinephrine. The final step in epinephrine biosynthesis is the methylation of the primary amine of ... The adrenal glands contribute about 7% of circulating norepinephrine, most of which is a spill over from neurotransmission with ... Patients with BFT were found to have increased plasma epinephrine, but not norepinephrine. Low, or absent, concentrations of ... The term "adrenergic" is often misinterpreted in that the main sympathetic neurotransmitter is norepinephrine (noradrenaline), ...
*  Adrenal medulla
It is the innermost part of the adrenal gland, consisting of cells that secrete epinephrine (adrenaline), norepinephrine ( ... norepinephrine, and dopamine. Because the ANS, specifically the sympathetic division, exerts direct control over the chromaffin ... the entire body cannot efficiently produce epinephrine and norepinephrine from dopamine, this results in severe dysautonomia ... but most crucially due to autonomous nervous system failure which requires epinephrine and norepinephrine as neurotransmitters ...
*  RTI-113
Sofuoglu M, Sewell RA (April 2009). "Norepinephrine and stimulant addiction". Addiction Biology. 14 (2): 119-129. doi:10.1111/j ...
*  Etoperidone
... norepinephrine transporter (20,000 nM) > dopamine transporter (52,000 nM). Etoperidone is metabolized in part to meta- ...